d-glucosyl-β-(1-4)-d-glucose
Botanicalexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT01716910)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 1-beta-d-glucopyranosyl-4-d-glucopyranose
- 1-beta-d-glucopyranosyl-4-d-glucopyranose
- 4-beta-d-glucopyranosyl-d-glucopyranose
- 4-beta-d-glucopyranosyl-d-glucopyranose
- 4-o-beta-d-glucopyranosyl-d-glucose
- 4-o-beta-d-glucopyranosyl-d-glucose
- 4-o-β-d-glucopyranosyl-d-glucopyranose
- 4-o-β-d-glucopyranosyl-d-glucopyranose
- 4-β-d-glucopyranosyl-d-glucopyranose
- 4-β-d-glucopyranosyl-d-glucopyranose
- cellobiose
- cellobiose
- cellobiose
- cellose
- cellose
- d-cellobiose
- d-cellobiose
- d-(+)-cellobiose
- d-(+)-cellobiose
- d-glucosyl-β-(1-4)-d-glucose
- d-glucosyl-β-(1-4)-d-glucose
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01716910 | Early Phase 1 (Phase 1) | Mar 1, 2011 | University of Copenhagen |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2011 |
1 organizations
Page 1 / 1